A phase II study of afatinib alone or combined with bevacizumab in chemo-naïve patients with advanced non-small cell lung cancer harboring EGFR mutations: AfaBev-CS study protocol
Ninomiya, Takashi, Ishikawa, Nobuhisa, Inoue, Koji, Kubo, Toshio, Yasugi, Masayuki, Shibayama, Takuo, Tadashi, Maeda, Fujitaka, Kazunori, Kodani, Masahiro, Yokoyama, Toshihide, Kuyama, Shoichi, Ochi,Language:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2018.10.008
Date:
November, 2018
File:
PDF, 2.21 MB
english, 2018